Retinoic acid, a metabolite of vitamin A and modulator of T cell immunity, has a favorable result in the treatment of lung cancer by suppressing Nrf2-related antioxidants in combination with cisplatin. This evidence concerns the gene NFE2L2 and lung carcinoma.